While Ki-67 results did not show significant suppression of proliferation, the partial reversal of cancer-related metabolism in the PCa+MAT group suggests that matrine’s therapeutic effects may prioritize metabolic reprogramming and necrosis induction over direct inhibition of proliferative signaling. Here, MKI67 is linked to cancer.